Resumen
Introduction: Diabetic nephropathy is a disease that increases morbidity, mortality, and health care costs. In addition, it is often present at the time of diagnosis of diabetes mellitus. A risk factor for its development is microalbuminuria. Objectives: To determine the incidence of diabetic nephropathy in patients with diabetes mellitus and their demographic characteristics. Methodology: Cross-sectional descriptive study in adult outpatients from the Hospital de Obras Sociales del Santo Hermano Pedro with diabetes mellitus, in whom microalbuminuria levels are quantified using reactive strips. Results: 90% of the patients diagnosed with diabetes presented microalbuminuria, which showed a direct correlation with age. The most frequent level of microalbuminuria was of 20 mg/L, and males presented higher levels of microalbuminuria. Conclusion: The prevalence of microalbuminuria in the sample of diabetic patients suggests that 90% of participants already have or are at risk of developing diabetic nephropathy.
Citas
World Health Organization. World Health Statistics 2014. Geneva: 2014. http://apps.who.int/iris/bitstream/handle/10665/112738/9789240692671_eng.pdf;jsessionid=62A9F01F4780E08D7C381A4B16C2A1FD?sequence=1
World Health Organization. WHO Mortality Database. Geneva: 2023. https://platform.who.int/mortality
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2014, January; 37(Supplement 1): S81 - S90. https://doi.org/10.2337/dc14-S081
Lopez-Giacoman, S., & Madero, M. Biomarkers in chronic kidney disease, from kidney function to kidney damage. World journal of nephrology, 2015, February; 4(1): 57–73. https://doi.org/10.5527/wjn.v4.i1.57
National Institute of Health; National Institute of Diabetes and Digestive and Kidney Diseases. United States Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. American J. Kidney Dis. 2016, March; 63(3): A7-A8. https://doi.org/10.1053/j.ajkd.2016.12.004
Afkarian, M., Zelnick, L.R., Hall, Y.N., Heagerty, P.J., Tuttle, K., Weiss, N.S., de Boer, I.H. Clinical manifestations of kidney disease among US Adults with diabetes, 1988-2014. JAMA, 2016, August; 316(6): 602–610. https://doi.org/10.1001/jama.2016.10924
de Boer, I.H., Rue, T.C., Hall, Y.N., Heagerty, P.J., Weiss, N.S., Himmelfarb, J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA, 2011, June; 305(24): 2532–2539. https://doi.org/10.1001/jama.2011.861
Kramer, H.J., Nguyen, Q.D., Curhan, G., Hsu C.-Y. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA, 2003, June; 289(24): 3273–3277. https://doi.org/10.1001/jama.289.24.3273
Molitch, M.E., Steffes, M., Sun, W., Rutledge, B., Cleary, P., de Boer, I.H., Zinman, B., Lachin, J.; Epidemiology of Diabetes Interventions and Complications Study Group. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. Diabetes Care, 2010, July; 33(7): 1536–1543. https://doi.org/10.2337/dc09-1098
Levey, A.S., Coresh, J., Balk, E., Kausz, A.T., Levin, A., Steffes, M.W., Hogg, R.J., Perrone, R.D., Lau, J., Eknyan, G.; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med, 2003, July; 139(2): 137–147. https://doi.org/10.7326/0003-4819-139-2-200307150-00013
Fox, C.S., Matsushita, K., Woodward, M., Bilo, H.J.G., Chalmers, J., Lambers Heerspink, H.J., Lee, B.J., Perkins, R.M., Rossing, P., Sairenchi, T., Tonelli, M., Vassalotti, J.A., Yamagishi, K., Coresh, J., de Jong, P.E., Wen, C.-P., Nelson, R.G.; Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet, 2012, November; 380(9854): 1662–1673. https://doi.org/10.1016/S0140-6736(12)61350-6
National Kidney Foundation. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl., 2013, January; 3(1): 1–150. https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf
Flynn, C., Bakris, G.L. Noninsulin glucose-lowering agents for the treatment of patients on dialysis. Nat Rev Nephrol., 2013, March; 9(3): 147–153. https://doi.org/10.1038/nrneph.2013.12
Matzke, G.R., Aronoff, G.R., Atkinson Jr., A.J., Bennett, W.M., Decker, B.S., Eckardt, K.-U., Golper, T., Grabe, D.W., Kasiske, B Keller, F., Kielstein, J.T., Mehta, R., Mueller, B.A., Pasko, D.A., Shaefer, F., Sica, D.A., Inker, L.A., Umans, J.G., Murray, P. Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int., 2011, December; 80(11): 1122–1137. https://doi.org/10.1038/ki.2011.322
de Boer, I.H., Gao, X., Cleary, P.A., Betu, I., Lachin, J.M., Molitch, M.E., Orchard, T., Paterson, A.D., Perkings, B.A., Steffes, M.W., Zinman, B. ; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Albuminuria changes and cardiovascular and renal outcomes in type 1 diabetes: the DCCT/EDICstudy. Clin. J.Am.Soc. Nephrol. 2016, November; 11(11): 1969–1977. https://doi.org/10.2215/CJN.02870316
Sumida, K., Molnar M.Z., Potukuchi, P.K., Koshy, G., Fridtjof, T., Jun, J.L., Changes in albuminuria and subsequent risk of incident kidney disease. Clin J Am Soc Nephrol, 2017, December; 12(12): 1941–1949. https://doi.org/10.2215/CJN.02720317
Hughes-Austin, J.M., Rifkin, D.E., Beben, T., Katz, R., Sanark, M.J., Deo, R., Hoofnagle, A.N., Homma, S., Siscovick, D.S., Sotoodehnia, N., Psaty, B.M., de Boer, I.H. Kestenbum, B., Shlipak, M.G., Ix, J.H. The relation of serum potassium concentration with cardiovascular events and mortality in community-living individuals. Clin J Am Soc Nephrol 2017, February; 12(2): 245–252. https://doi.org/10.2215/CJN.06290616
Ghaderian, S.B., Hayati, F., Shayanpour, S., Beladi Mousavi, S.S. Diabetes and end-stage renal disease; a review article on new concepts. J Renal Inj Prev. 2015, June; 4(2): 28-33. https://doi.org/10.12861/jrip.2015.07
Copyright
License
Copyright (c) 2022 Julio Rubén Rodas Garzaro, Jennifer Joanne Greenberg Godoy y Álvaro Pineda Fuentes
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish in this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License 4.0 (CC BY-NC_SA 4.0) that indicates: a) It is allowed that others share the work, with an acknowledgement of the work's authorship and initial publication in this journal, b) The work may not be used for commercial purposes, c) If it's remixed, transformed, or built upon the material, one must distribute the contributions under the same license as the original
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository, website or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
